AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Domperidone in South Africa
7 products registered with SAHPRA — 5 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| VOMIDON SUSPENSION | 31/5.7.2/0331 | Ranbaxy (SA) (Pty) Ltd | suspended | 29 Jul 2025 |
| MOTILIUM 1 mg/ml | V/5.7.2/19 | Janssen Pharmaceutica (Pty) Ltd | suspended | 12 May 2023 |
| VOMIDON TABLETS | 31/5.7.2/0330 | Ranbaxy (SA) (Pty) Ltd | active | 1 Jan 1900 |
| DOMPERIDONE CIPLA | 52/5.7.2/0563 | Cipla Medpro (Pty) Ltd | active | 1 Jan 1900 |
| MOTILIUM | K/5.7.2/261 | Johnson & Johnson (Pty) Ltd û Cape Town | active | 1 Jan 1900 |
| BIO DOMPERIDONE 10 | 42/5.7.2/0836 | Biotech Laboratories (Pty) Ltd | active | 1 Jan 1900 |
| VOMI-GUARD 10 mg TABLETS | A38/5.7.2/0636 | Austell Pharmaceuticals (Pty) Ltd | active | 1 Jan 1900 |
Domperidone — SAHPRA Registration Details
SAHPRA (South Africa) has 7 registered products containing Domperidone, of which 5 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Domperidone registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.